证券代码：688353 证券简称：华盛锂电 公告编号：2025-071 江苏华盛锂电材料股份有限公司 股票交易异常波动公告 二、公司关注并核实的相关情况 针对公司股票交易异常波动的情况，公司对有关事项进行了核查，现将有 关情况说明如下： 1、经公司自查，公司目前生产经营活动一切正常，市场环境、行业政策没 有发生重大调整、生产成本和销售等情况没有出现大幅波动、内部生产经营秩 序正常。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 江苏华盛锂电材料股份有限公司（以下简称"公司"）股票交易价格连 续三个交易日（2025 年 11 月 4 日、2025 年 11 月 5 日、2025 年 11 月 6 日）内 收盘价格涨幅偏离值累计达到 30%。根据《上海证券交易所交易规则》《上海证 券交易所科创板股票异常交易实时监控细则》的有关规定，属于股票交易异常 波动的情形。 经公司自查，并向控股股东及实际控制人核实，截至本公告披露日，公 司及控股股东、实际控制人不存在应披露而未披露的重大信息。 公司股票价格短期波动幅度较大， ...

11月6日沪指上涨0.97%，盘后龙虎榜数据显示，机构现身28只个股龙虎榜，净买入9只，净卖出19只。 深沪股通席位出现在20只个股龙虎榜。 大为股份，因日换手率达38.96%上榜龙虎榜，前五大买卖营业部中有6家机构专用席位，为买一、买 二、买三、卖一、卖三、卖四，合计净卖出9045.11万元。资金流向方面，该股全天资金净流出2.34亿 元。 证券时报·数据宝统计显示，11月6日机构专用席位现身28只个股龙虎榜，合计净卖出1.05亿元。个股来 看，净买入9只，净卖出19只。 机构龙虎榜净买卖个股 机构专用席位净买入金额最多的是海科新源，该股今日收盘上涨16.23%，全天换手率为49.04%，成交 额为15.31亿元。因日换手率达49.04%、日收盘价涨幅达16.23%上榜龙虎榜，前五大买卖营业部中有9家 机构专用席位，为买一、买二、买三、买四、买五、卖一、卖二、卖三、卖五，合计净买入17582.62万 元。资金流向方面，该股全天资金净流入1.05亿元。 华盛锂电，今日收盘涨停，全天换手率为15.75%，成交额为11.52亿元。因日收盘价涨幅达20.00%上榜 龙虎榜，前五大买卖营业部中有1家机构专用席位，为买 ...

Core Points - On November 6, Huasheng Lithium (688353) closed at 65.04 yuan, reaching the daily limit with a trading volume of 1.152 billion yuan and a turnover rate of 15.75% [2] - The stock was listed on the daily trading bulletin due to a price increase of 15% [2] - The top five trading departments accounted for a total transaction of 463 million yuan, with a net buying amount of 109 million yuan [2] Trading Activity - The main buying department included one institutional special seat, which purchased 150.5444 million yuan worth of shares, contributing to a total buying amount of 135 million yuan [3] - The leading selling department was Goldman Sachs (China) Securities, which sold shares worth 47.6274 million yuan [3] - Overall, institutional special seats had a net buying of 151 million yuan on that day [2][3] Fund Flow - The stock experienced a net inflow of 40.0588 million yuan in main funds throughout the day [3] - Over the past six months, the stock has appeared on the trading bulletin five times, with an average price drop of 2.50% the day after being listed and an average decline of 1.13% over the following five days [3]

华盛锂电11月6日公告，公司股票交易连续三个交易日收盘价格涨幅偏离值累计达到30%，属于股票交 易异常波动情形。经自查，公司目前生产经营活动一切正常，市场环境、行业政策没有发生重大调整。 2025年三季度，公司营业收入5.39亿元，同比上涨62.29%；归属于上市公司股东的净利润亏损1.03亿 元。但由于下游锂电行业的恢复仍面临着不确定性，以及公司的降本增效仍在持续进行中，公司仍然面 临业绩下滑或亏损的风险。 ...

11月6日，A股市场整体上涨。 截至收盘，上证指数收报4007.76点，上涨0.97%；深证成指收报13452.42点，上涨1.73%；创业板指收报3224.62点，上涨1.84%。两市合计成交20552.48亿 元，较上一交易日增加1829.06亿元。 1. 两市主力资金净流出近38亿元 今日沪深两市主力资金开盘净流出79.34亿元，尾盘主力资金净流入16.08亿元，两市全天主力资金净流出37.98亿元。 4. 主力资金净流入居前20股 5.机构龙虎榜 | 证券简称 | 日涨跌幅 | 机构带头入额 （万 | | --- | --- | --- | | | | 元） | | 海科新源 | 16.23% | 17582.62 | | 华盛锂电 | 20.00% | 15054.44 | | 中能电气 | 7.93% | 4213.20 | | 麦格米特 | 10.00% | 3778.45 | | 长米华芯 | 20.00% | 3594.17 | | 海峡股份 | -7.66% | 2157.51 | | 锦华新材 | -2.82% | 1637.98 | | 崇德科技 | 18.53% | 1361.85 ...

Group 1 - The acquisition of Upwind New Materials has been completed, with Zhiyuan Hengyue increasing its shareholding to 58.62% [1] - Zhiyuan Hengyue and its concerted actions hold a total of 63.62% of Upwind New Materials [1] - The third board meeting will review the nomination of non-independent and independent director candidates [1] Group 2 - Tianci Materials' subsidiary, Jiujiang Tianci, signed a framework agreement to supply 87 million tons of electrolyte products to Guoxuan High-Tech from 2026 to 2028 [2] - Tianci Materials also signed a framework agreement with Zhongchuang Xinhang to supply 72.5 million tons of electrolyte products during the same period [2] Group 3 - Xingwang Yuda has regained its qualification to participate in military procurement activities after being removed from the prohibited list [3] - The restoration of qualification is expected to positively impact the company's normal operations and development [3] Group 4 - Zhongjian Technology signed a procurement contract worth 563 million yuan, accounting for 69.34% of its recent fiscal year's main business income [4] Group 5 - Duofluoride's subsidiary has begun delivering boron isotope products after receiving an order from a subsidiary of China General Nuclear Power Group [5] - The company has established a production line capable of producing 100 tons per year of boron stable isotope materials [5] Group 6 - New Hope plans to establish a joint venture with state-owned and underdeveloped funds to invest in pig farming, with a registered capital of 2.87 billion yuan [6] - The joint venture will acquire 100% of certain subsidiaries and establish 16 new subsidiaries in key support areas [6] Group 7 - Sudavige intends to acquire 51% of Changzhou Weipu Semiconductor Equipment Co., Ltd. for 510 million yuan, which will become a subsidiary [7] - The acquisition is expected to enhance the company's capabilities in semiconductor equipment [7] Group 8 - BGI Genomics has adjusted its 2025 revenue forecast to between 36.2 billion and 38.1 billion yuan, driven by the leading position of Baiyueze in the U.S. market [11][12]

Group 1 - Institutions ranked 36 stocks today, with net purchases in 19 stocks and net sales in 17 stocks. The top three stocks with the highest net purchases were Huasheng Lithium Power (222 million), Haike Xinyuan (176 million), and Shun Sodium Co. (75.2 million) [1] - Haike Xinyuan is a leading electrolyte solvent company in China, with a total production capacity exceeding 700,000 tons and a significant proportion of high-end solvent products compared to peers [2] - Ceres Power announced a manufacturing license agreement with Weichai Power for solid oxide fuel cells (SOFC), which will lead to the establishment of a new factory to produce batteries and stacks for data centers and commercial power markets [3] Group 2 - Triangular Defense signed a gas turbine project development agreement and a framework order agreement with Siemens Energy and Siemens Energy Canada [4] - The yellow phosphorus index increased by 4% on November 5, with a cumulative increase of over 7% in the past two weeks [5]

Group 1: Strong Individual Stocks - As of November 6, the Shanghai Composite Index rose by 0.97% to 4007.76 points, the Shenzhen Component Index increased by 1.73% to 13452.42 points, and the ChiNext Index climbed by 1.84% to 3224.62 points [1] - A total of 72 stocks in the A-share market hit the daily limit up, with the top three strong stocks being HeFu China (603122) with 8 consecutive limit ups, YaBang Co. (603188) with 2 limit ups in 4 days, and HuaSheng Lithium (688353) with its first limit up [1] - Detailed data for the top 10 strong stocks includes their stock codes, names, consecutive limit ups, turnover rates, and closing prices [1] Group 2: Strong Concept Sectors - The top three concept sectors based on A-share performance are Phosphate Chemical Industry with a rise of 3.92%, National Big Fund Holdings with an increase of 2.67%, and PVDF Concept with a gain of 2.5% [2][3] - The top 10 concept sectors are listed with their respective percentage changes, indicating a general positive trend across various sectors [3]

Core Viewpoint - The article discusses the upcoming fourth batch of traditional Chinese medicine (TCM) procurement, highlighting the challenges and changes in the procurement process, including the inclusion of unique products and OTC varieties, as well as the complexities of pricing and quality evaluation in TCM procurement [4][11][12]. Group 1: Procurement Details - The fourth batch of TCM procurement will involve 90 drugs divided into 28 procurement groups, which is an increase in the number of groups compared to previous batches [6]. - The previous batches involved 17 groups with 76 drugs, 16 groups with 42 drugs, and 20 groups with 95 drugs, indicating a trend of increasing complexity in the procurement process [6]. - The procurement will officially start on November 10, with data submission required by November 21 [4]. Group 2: Unique Products and Challenges - The current procurement includes several unique products, such as Yindan Xinnao Tong soft capsules and Yinxin Ertianshu injection, which have faced challenges in previous procurement rounds due to high concentration and pricing difficulties [8][11]. - The high concentration of unique products in TCM leads to challenges in competitive pricing, as many unique products lack substitutes, making it difficult for companies to lower prices [8][12]. Group 3: Quality and Pricing Issues - TCM procurement faces difficulties in achieving complete coverage, competitive pricing, and quality evaluation due to the vast number of products and significant price discrepancies among similar products [11][12]. - For instance, the price of Chuanxinlian tablets varies significantly, with the lowest price at 0.072 yuan and the highest at 1.09 yuan, a difference of over 15 times [12]. - The article emphasizes the need for a comprehensive quality evaluation system for TCM, which includes production quality, clinical recognition, and safety monitoring to ensure consistent quality across different manufacturers [13].

Core Points - The Sci-Tech Innovation Board (STAR Market) index rose by 3.34%, closing at 1436.86 points, with a total trading volume of 4.16 billion shares and a turnover of 217.87 billion yuan [1] - Among the tradable stocks on the STAR Market, 405 stocks closed higher, with 10 stocks rising over 10%, including Changguang Huaxin and Huasheng Lithium, which hit the daily limit [1] - The turnover rate for STAR Market stocks showed that 3 stocks had a turnover rate exceeding 20%, while 16 stocks had a turnover rate between 10% and 20% [1] Trading Performance - The stocks with the highest turnover rates included Heyuan Biological, which closed down 8.74% with a turnover rate of 39.70%, and Bibet, which closed down 5.14% with a turnover rate of 22.78% [1][3] - The top gainers included Changguang Huaxin and Huasheng Lithium, both up by 20.00%, while the largest decliners were Aerospace Hongtu and Heyuan Biological, down by 15.92% and 8.74%, respectively [2] Sector Analysis - The electronics sector had the most stocks with a turnover rate exceeding 5%, totaling 21 stocks, followed by the power equipment and defense sectors with 15 and 6 stocks, respectively [2] - In terms of capital flow, 38 stocks experienced net inflows from main funds, with the highest inflows seen in Canxin Technology, Western Superconducting, and Purun Technology, amounting to 267 million yuan, 198 million yuan, and 195 million yuan, respectively [2] Leverage Fund Movements - A total of 33 stocks received net purchases from leveraged funds, with the largest increases in financing balances seen in Artis, GuoDun Quantum, and Trina Solar, which increased by 544 million yuan, 395 million yuan, and 274 million yuan, respectively [2]